RARE-X Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • RARE-X's estimated annual revenue is currently $1.1M per year.(i)
  • RARE-X's estimated revenue per employee is $135,000

Employee Data

  • RARE-X has 8 Employees.(i)
  • RARE-X grew their employee count by -20% last year.

RARE-X's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.3M156-3%N/AN/A
#2
$148.5M440N/AN/AN/A
#3
$124.2M36846%N/AN/A
#4
$545.1M144217%N/AN/A
#5
$29.2M1086%N/AN/A
#6
$12.9M53N/AN/AN/A
#7
$1125.1M29146%$20.4MN/A
#8
$15.3M6315%N/AN/A
#9
$8.9M415%N/AN/A
#10
$4.3M23-15%N/AN/A
Add Company

What Is RARE-X?

Removing barriers to access in support of accelerating rare disease diagnosis, open patient-owned data collection and federated data access for research. RARE-X is bringing forward a technology platform and novel patient support that will generate more critical rare disease data and improve data quality, that will support the acceleration of research and clinical trial readiness. All Patient Owned and Stewarded.

keywords:N/A

N/A

Total Funding

8

Number of Employees

$1.1M

Revenue (est)

-20%

Employee Growth %

N/A

Valuation

N/A

Accelerator

RARE-X News

2022-04-19 - FIFA 22 Patrick Vieira SBC: How to unlock the BRILLIANT ...

Reward - 1 x Rare Players Pack. Estimated Cost - TBC. If you want to try the card out before investing, you can unlock Vieira on a 5-match...

2022-04-17 - Telegraph Art and Comics home to rare X-Men comic

ALBEMARLE COUNTY, Va. (WVIR) - A rare comic book recently made its way to a store in Albemarle County, and the price of it may shock you.

2022-04-06 - RARE-X Study Delivers Insights for Diversity, Equality, and ...

WASHINGTON, April 7, 2022 /PRNewswire-PRWeb/ -- RARE-X, a nonprofit organization dedicated to enabling patient communities to easily collect,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.8M80%N/A
#2
$0.8M8N/AN/A
#3
$0.6M8-20%N/A
#4
$1.1M90%N/A
#5
$0.7M9N/AN/A